id	sid	tid	token	lemma	pos
dpc-1530	1	1	dermatology	dermatology	NOUN
dpc-1530	1	2	:	:	PUNCT
dpc-1530	1	3	practical	practical	ADJ
dpc-1530	1	4	and	and	CCONJ
dpc-1530	1	5	conceptual	conceptual	ADJ
dpc-1530	1	6	dermatology	dermatology	NOUN
dpc-1530	1	7	practical	practical	ADJ
dpc-1530	1	8	&	&	CCONJ
dpc-1530	1	9	conceptual	conceptual	ADJ
dpc-1530	1	10	letter	letter	NOUN
dpc-1530	2	1	|	|	ADV
dpc-1530	2	2	dermatol	dermatol	ADJ
dpc-1530	2	3	pract	pract	NOUN
dpc-1530	2	4	concept	concept	NOUN
dpc-1530	2	5	.	.	PUNCT
dpc-1530	2	6	2021	2021	NUM
dpc-1530	2	7	;	;	PUNCT
dpc-1530	2	8	11(3	11(3	NUM
dpc-1530	2	9	):	):	PUNCT
dpc-1530	2	10	e2021029	e2021029	PROPN
dpc-1530	2	11	1	1	NUM
dpc-1530	2	12	serum	serum	NOUN
dpc-1530	2	13	sickness	sickness	NOUN
dpc-1530	2	14	-	-	PUNCT
dpc-1530	2	15	like	like	ADJ
dpc-1530	2	16	reaction	reaction	NOUN
dpc-1530	2	17	:	:	PUNCT
dpc-1530	2	18	drug	drug	NOUN
dpc-1530	2	19	-	-	PUNCT
dpc-1530	2	20	induced	induce	VERB
dpc-1530	2	21	cutaneous	cutaneous	ADJ
dpc-1530	2	22	disease	disease	NOUN
dpc-1530	2	23	in	in	ADP
dpc-1530	2	24	a	a	DET
dpc-1530	2	25	child	child	NOUN
dpc-1530	2	26	ana	ana	PROPN
dpc-1530	2	27	carolina	carolina	PROPN
dpc-1530	2	28	galvão	galvão	PROPN
dpc-1530	2	29	dos	do	VERB
dpc-1530	2	30	santos	santos	PROPN
dpc-1530	2	31	de	de	ADP
dpc-1530	2	32	araujo1	araujo1	PROPN
dpc-1530	2	33	,	,	PUNCT
dpc-1530	2	34	liana	liana	PROPN
dpc-1530	2	35	moura	moura	PROPN
dpc-1530	2	36	de	de	ADP
dpc-1530	2	37	almeida1	almeida1	PROPN
dpc-1530	2	38	,	,	PUNCT
dpc-1530	2	39	ana	ana	PROPN
dpc-1530	2	40	paula	paula	PROPN
dpc-1530	2	41	moura	moura	PROPN
dpc-1530	2	42	de	de	PROPN
dpc-1530	2	43	almeida1	almeida1	PROPN
dpc-1530	2	44	,	,	PUNCT
dpc-1530	2	45	elisa	elisa	PROPN
dpc-1530	2	46	fontenelle	fontenelle	PROPN
dpc-1530	2	47	de	de	X
dpc-1530	2	48	oliveira2	oliveira2	PROPN
dpc-1530	2	49	,	,	PUNCT
dpc-1530	2	50	mayra	mayra	PROPN
dpc-1530	2	51	carrijo	carrijo	PROPN
dpc-1530	2	52	rochael3	rochael3	PROPN
dpc-1530	2	53	,	,	PUNCT
dpc-1530	2	54	rodrigo	rodrigo	PROPN
dpc-1530	2	55	aires	aires	PROPN
dpc-1530	2	56	de	de	PROPN
dpc-1530	2	57	morais4	morais4	PROPN
dpc-1530	2	58	,	,	PUNCT
dpc-1530	2	59	hudson	hudson	PROPN
dpc-1530	2	60	dutra	dutra	PROPN
dpc-1530	2	61	rezende1	rezende1	PROPN
dpc-1530	2	62	1	1	NUM
dpc-1530	2	63	álvaro	álvaro	NOUN
dpc-1530	2	64	alvim	alvim	ADP
dpc-1530	2	65	school	school	NOUN
dpc-1530	2	66	hospital	hospital	NOUN
dpc-1530	2	67	.	.	PUNCT
dpc-1530	3	1	department	department	NOUN
dpc-1530	3	2	of	of	ADP
dpc-1530	3	3	dermatology	dermatology	NOUN
dpc-1530	3	4	.	.	PUNCT
dpc-1530	4	1	campos	campos	PROPN
dpc-1530	4	2	dos	dos	PROPN
dpc-1530	4	3	goytacazes	goytacaze	NOUN
dpc-1530	4	4	,	,	PUNCT
dpc-1530	4	5	rio	rio	PROPN
dpc-1530	4	6	de	de	PROPN
dpc-1530	4	7	janeiro	janeiro	PROPN
dpc-1530	4	8	,	,	PUNCT
dpc-1530	4	9	brazil	brazil	PROPN
dpc-1530	4	10	.	.	PUNCT
dpc-1530	5	1	2	2	NUM
dpc-1530	5	2	fernandes	fernandes	PROPN
dpc-1530	5	3	figueira	figueira	PROPN
dpc-1530	5	4	institute	institute	PROPN
dpc-1530	5	5	/	/	SYM
dpc-1530	5	6	fiocruz	fiocruz	PROPN
dpc-1530	5	7	.	.	PUNCT
dpc-1530	6	1	department	department	NOUN
dpc-1530	6	2	of	of	ADP
dpc-1530	6	3	pediatric	pediatric	ADJ
dpc-1530	6	4	dermatology	dermatology	NOUN
dpc-1530	6	5	.	.	PUNCT
dpc-1530	7	1	rio	rio	PROPN
dpc-1530	7	2	de	de	PROPN
dpc-1530	7	3	janeiro	janeiro	PROPN
dpc-1530	7	4	,	,	PUNCT
dpc-1530	7	5	rio	rio	PROPN
dpc-1530	7	6	de	de	PROPN
dpc-1530	7	7	janeiro	janeiro	PROPN
dpc-1530	7	8	,	,	PUNCT
dpc-1530	7	9	brazil	brazil	PROPN
dpc-1530	7	10	.	.	PUNCT
dpc-1530	8	1	3	3	NUM
dpc-1530	8	2	fluminense	fluminense	PROPN
dpc-1530	8	3	federal	federal	PROPN
dpc-1530	8	4	university	university	PROPN
dpc-1530	8	5	.	.	PUNCT
dpc-1530	9	1	department	department	PROPN
dpc-1530	9	2	of	of	ADP
dpc-1530	9	3	pathology	pathology	PROPN
dpc-1530	9	4	.	.	PUNCT
dpc-1530	10	1	niterói	niterói	PROPN
dpc-1530	10	2	,	,	PUNCT
dpc-1530	10	3	rio	rio	PROPN
dpc-1530	10	4	de	de	PROPN
dpc-1530	10	5	janeiro	janeiro	PROPN
dpc-1530	10	6	,	,	PUNCT
dpc-1530	10	7	brazil	brazil	PROPN
dpc-1530	10	8	.	.	PUNCT
dpc-1530	11	1	4	4	NUM
dpc-1530	11	2	campos	campos	PROPN
dpc-1530	11	3	dos	do	NOUN
dpc-1530	11	4	goytacazes	goytacaze	NOUN
dpc-1530	11	5	,	,	PUNCT
dpc-1530	11	6	rio	rio	PROPN
dpc-1530	11	7	de	de	PROPN
dpc-1530	11	8	janeiro	janeiro	PROPN
dpc-1530	11	9	,	,	PUNCT
dpc-1530	11	10	brazil	brazil	PROPN
dpc-1530	11	11	.	.	PUNCT
dpc-1530	12	1	key	key	ADJ
dpc-1530	12	2	words	word	NOUN
dpc-1530	12	3	:	:	PUNCT
dpc-1530	12	4	serum	serum	NOUN
dpc-1530	12	5	sickness	sickness	NOUN
dpc-1530	12	6	,	,	PUNCT
dpc-1530	12	7	drug	drug	NOUN
dpc-1530	12	8	hypersensitivity	hypersensitivity	NOUN
dpc-1530	12	9	,	,	PUNCT
dpc-1530	12	10	allergic	allergic	ADJ
dpc-1530	12	11	reaction	reaction	NOUN
dpc-1530	12	12	,	,	PUNCT
dpc-1530	12	13	anti	anti	ADJ
dpc-1530	12	14	-	-	ADJ
dpc-1530	12	15	bacterial	bacterial	ADJ
dpc-1530	12	16	agents	agent	NOUN
dpc-1530	12	17	,	,	PUNCT
dpc-1530	12	18	clavulanic	clavulanic	ADJ
dpc-1530	12	19	acid	acid	NOUN
dpc-1530	12	20	.	.	PUNCT
dpc-1530	13	1	citation	citation	NOUN
dpc-1530	13	2	:	:	PUNCT
dpc-1530	13	3	galvão	galvão	NOUN
dpc-1530	13	4	dos	dos	PROPN
dpc-1530	13	5	santos	santos	PROPN
dpc-1530	13	6	de	de	PROPN
dpc-1530	13	7	araujo	araujo	PROPN
dpc-1530	13	8	ac	ac	PROPN
dpc-1530	13	9	,	,	PUNCT
dpc-1530	13	10	moura	moura	PROPN
dpc-1530	13	11	de	de	PROPN
dpc-1530	13	12	almeida	almeida	PROPN
dpc-1530	13	13	l	l	PROPN
dpc-1530	13	14	,	,	PUNCT
dpc-1530	13	15	moura	moura	PROPN
dpc-1530	13	16	de	de	PROPN
dpc-1530	13	17	almeida	almeida	PROPN
dpc-1530	13	18	ap	ap	PROPN
dpc-1530	13	19	,	,	PUNCT
dpc-1530	13	20	fontenelle	fontenelle	PROPN
dpc-1530	13	21	de	de	PROPN
dpc-1530	13	22	oliveira	oliveira	PROPN
dpc-1530	13	23	e	e	PROPN
dpc-1530	13	24	,	,	PUNCT
dpc-1530	13	25	carrijo	carrijo	PROPN
dpc-1530	13	26	rochael	rochael	PROPN
dpc-1530	13	27	m	m	PROPN
dpc-1530	13	28	,	,	PUNCT
dpc-1530	13	29	aires	aires	PROPN
dpc-1530	13	30	de	de	PROPN
dpc-1530	13	31	morais	morais	PROPN
dpc-1530	13	32	r	r	PROPN
dpc-1530	13	33	,	,	PUNCT
dpc-1530	13	34	rezende	rezende	PROPN
dpc-1530	13	35	hd	hd	PROPN
dpc-1530	13	36	.	.	PUNCT
dpc-1530	14	1	serum	serum	PROPN
dpc-1530	14	2	sickness	sickness	NOUN
dpc-1530	14	3	-	-	PUNCT
dpc-1530	14	4	like	like	ADJ
dpc-1530	14	5	reaction	reaction	NOUN
dpc-1530	14	6	:	:	PUNCT
dpc-1530	14	7	drug	drug	NOUN
dpc-1530	14	8	-	-	PUNCT
dpc-1530	14	9	induced	induce	VERB
dpc-1530	14	10	cutaneous	cutaneous	ADJ
dpc-1530	14	11	disease	disease	NOUN
dpc-1530	14	12	in	in	ADP
dpc-1530	14	13	a	a	DET
dpc-1530	14	14	child	child	NOUN
dpc-1530	14	15	.	.	PUNCT
dpc-1530	15	1	dermatol	dermatol	NOUN
dpc-1530	15	2	pract	pract	PROPN
dpc-1530	15	3	concept	concept	NOUN
dpc-1530	15	4	.	.	PUNCT
dpc-1530	16	1	2021	2021	NUM
dpc-1530	16	2	;	;	PUNCT
dpc-1530	17	1	11(3	11(3	NUM
dpc-1530	17	2	):	):	PUNCT
dpc-1530	17	3	e2021029	e2021029	PROPN
dpc-1530	17	4	.	.	PUNCT
dpc-1530	18	1	doi	doi	PROPN
dpc-1530	18	2	:	:	PUNCT
dpc-1530	18	3	https://doi.org/10.5826/dpc.1103a29	https://doi.org/10.5826/dpc.1103a29	NOUN
dpc-1530	18	4	accepted	accept	VERB
dpc-1530	18	5	:	:	PUNCT
dpc-1530	18	6	october	october	PROPN
dpc-1530	18	7	22	22	NUM
dpc-1530	18	8	,	,	PUNCT
dpc-1530	18	9	2020	2020	NUM
dpc-1530	18	10	;	;	PUNCT
dpc-1530	18	11	published	publish	VERB
dpc-1530	18	12	:	:	PUNCT
dpc-1530	18	13	july	july	PROPN
dpc-1530	18	14	8	8	NUM
dpc-1530	18	15	,	,	PUNCT
dpc-1530	18	16	2021	2021	NUM
dpc-1530	18	17	copyright	copyright	NOUN
dpc-1530	18	18	:	:	PUNCT
dpc-1530	18	19	©	©	PROPN
dpc-1530	18	20	2021	2021	NUM
dpc-1530	18	21	galvão	galvão	NOUN
dpc-1530	18	22	dos	do	NOUN
dpc-1530	18	23	santos	santos	PROPN
dpc-1530	18	24	de	de	PROPN
dpc-1530	18	25	araujo	araujo	PROPN
dpc-1530	18	26	et	et	PROPN
dpc-1530	18	27	al	al	PROPN
dpc-1530	18	28	.	.	PUNCT
dpc-1530	19	1	this	this	PRON
dpc-1530	19	2	is	be	AUX
dpc-1530	19	3	an	an	DET
dpc-1530	19	4	open	open	ADJ
dpc-1530	19	5	-	-	PUNCT
dpc-1530	19	6	access	access	NOUN
dpc-1530	19	7	article	article	NOUN
dpc-1530	19	8	distributed	distribute	VERB
dpc-1530	19	9	under	under	ADP
dpc-1530	19	10	the	the	DET
dpc-1530	19	11	terms	term	NOUN
dpc-1530	19	12	of	of	ADP
dpc-1530	19	13	the	the	DET
dpc-1530	19	14	creative	creative	ADJ
dpc-1530	19	15	commons	common	NOUN
dpc-1530	19	16	attribution	attribution	NOUN
dpc-1530	19	17	license	license	NOUN
dpc-1530	19	18	by	by	ADP
dpc-1530	19	19	-	-	PUNCT
dpc-1530	19	20	nc-4.0	nc-4.0	NOUN
dpc-1530	19	21	,	,	PUNCT
dpc-1530	19	22	which	which	PRON
dpc-1530	19	23	permits	permit	VERB
dpc-1530	19	24	unrestricted	unrestricted	ADJ
dpc-1530	19	25	noncommercial	noncommercial	ADJ
dpc-1530	19	26	use	use	NOUN
dpc-1530	19	27	,	,	PUNCT
dpc-1530	19	28	distribution	distribution	NOUN
dpc-1530	19	29	,	,	PUNCT
dpc-1530	19	30	and	and	CCONJ
dpc-1530	19	31	reproduction	reproduction	NOUN
dpc-1530	19	32	in	in	ADP
dpc-1530	19	33	any	any	DET
dpc-1530	19	34	medium	medium	NOUN
dpc-1530	19	35	,	,	PUNCT
dpc-1530	19	36	provided	provide	VERB
dpc-1530	19	37	the	the	DET
dpc-1530	19	38	original	original	ADJ
dpc-1530	19	39	authors	author	NOUN
dpc-1530	19	40	and	and	CCONJ
dpc-1530	19	41	source	source	NOUN
dpc-1530	19	42	are	be	AUX
dpc-1530	19	43	credited	credit	VERB
dpc-1530	19	44	.	.	PUNCT
dpc-1530	20	1	funding	funding	NOUN
dpc-1530	20	2	:	:	PUNCT
dpc-1530	20	3	none	none	NOUN
dpc-1530	20	4	.	.	PUNCT
dpc-1530	21	1	competing	compete	VERB
dpc-1530	21	2	interests	interest	NOUN
dpc-1530	21	3	:	:	PUNCT
dpc-1530	21	4	the	the	DET
dpc-1530	21	5	authors	author	NOUN
dpc-1530	21	6	have	have	VERB
dpc-1530	21	7	no	no	DET
dpc-1530	21	8	conflicts	conflict	NOUN
dpc-1530	21	9	of	of	ADP
dpc-1530	21	10	interest	interest	NOUN
dpc-1530	21	11	to	to	PART
dpc-1530	21	12	disclose	disclose	VERB
dpc-1530	21	13	.	.	PUNCT
dpc-1530	22	1	authorship	authorship	NOUN
dpc-1530	22	2	:	:	PUNCT
dpc-1530	22	3	all	all	DET
dpc-1530	22	4	authors	author	NOUN
dpc-1530	22	5	have	have	AUX
dpc-1530	22	6	contributed	contribute	VERB
dpc-1530	22	7	significantly	significantly	ADV
dpc-1530	22	8	to	to	ADP
dpc-1530	22	9	this	this	DET
dpc-1530	22	10	publication	publication	NOUN
dpc-1530	22	11	corresponding	correspond	VERB
dpc-1530	22	12	author	author	NOUN
dpc-1530	22	13	:	:	PUNCT
dpc-1530	22	14	ana	ana	PROPN
dpc-1530	22	15	carolina	carolina	PROPN
dpc-1530	22	16	galvão	galvão	PROPN
dpc-1530	22	17	dos	do	VERB
dpc-1530	22	18	santos	santos	PROPN
dpc-1530	22	19	de	de	PROPN
dpc-1530	22	20	araujo	araujo	PROPN
dpc-1530	22	21	,	,	PUNCT
dpc-1530	22	22	álvaro	álvaro	NOUN
dpc-1530	22	23	alvim	alvim	ADP
dpc-1530	22	24	school	school	NOUN
dpc-1530	22	25	hospital	hospital	NOUN
dpc-1530	22	26	.	.	PUNCT
dpc-1530	23	1	dermatology	dermatology	NOUN
dpc-1530	23	2	department	department	PROPN
dpc-1530	23	3	.	.	PUNCT
dpc-1530	24	1	campos	campos	PROPN
dpc-1530	24	2	dos	dos	PROPN
dpc-1530	24	3	goytacazes	goytacaze	NOUN
dpc-1530	24	4	,	,	PUNCT
dpc-1530	24	5	rio	rio	PROPN
dpc-1530	24	6	de	de	PROPN
dpc-1530	24	7	janeiro	janeiro	PROPN
dpc-1530	24	8	,	,	PUNCT
dpc-1530	24	9	brazil	brazil	PROPN
dpc-1530	24	10	.	.	PUNCT
dpc-1530	25	1	email	email	NOUN
dpc-1530	25	2	:	:	PUNCT
dpc-1530	25	3	anacarolinagsa@yahoo.com.br	anacarolinagsa@yahoo.com.br	ADJ
dpc-1530	25	4	introduction	introduction	NOUN
dpc-1530	25	5	serum	serum	NOUN
dpc-1530	25	6	sickness	sickness	PROPN
dpc-1530	25	7	is	be	AUX
dpc-1530	25	8	defined	define	VERB
dpc-1530	25	9	as	as	ADP
dpc-1530	25	10	a	a	DET
dpc-1530	25	11	type	type	NOUN
dpc-1530	25	12	iii	iii	NOUN
dpc-1530	25	13	hypersensitivity	hypersensitivity	NOUN
dpc-1530	25	14	reaction	reaction	NOUN
dpc-1530	25	15	,	,	PUNCT
dpc-1530	25	16	which	which	PRON
dpc-1530	25	17	leads	lead	VERB
dpc-1530	25	18	to	to	ADP
dpc-1530	25	19	complement	complement	VERB
dpc-1530	25	20	activation	activation	NOUN
dpc-1530	25	21	and	and	CCONJ
dpc-1530	25	22	hypocomplementemia	hypocomplementemia	NOUN
dpc-1530	25	23	,	,	PUNCT
dpc-1530	25	24	small	small	ADJ
dpc-1530	25	25	vessel	vessel	NOUN
dpc-1530	25	26	vasculitis	vasculitis	PROPN
dpc-1530	25	27	,	,	PUNCT
dpc-1530	25	28	and	and	CCONJ
dpc-1530	25	29	nephropathy	nephropathy	NOUN
dpc-1530	25	30	.	.	PUNCT
dpc-1530	26	1	from	from	ADP
dpc-1530	26	2	a	a	DET
dpc-1530	26	3	clinical	clinical	ADJ
dpc-1530	26	4	perspective	perspective	NOUN
dpc-1530	26	5	it	it	PRON
dpc-1530	26	6	resembles	resemble	VERB
dpc-1530	26	7	serum	serum	NOUN
dpc-1530	26	8	sickness	sickness	NOUN
dpc-1530	26	9	-	-	PUNCT
dpc-1530	26	10	like	like	ADJ
dpc-1530	26	11	reaction	reaction	NOUN
dpc-1530	26	12	(	(	PUNCT
dpc-1530	26	13	sslr	sslr	PROPN
dpc-1530	26	14	)	)	PUNCT
dpc-1530	26	15	,	,	PUNCT
dpc-1530	26	16	presenting	present	VERB
dpc-1530	26	17	clinical	clinical	ADJ
dpc-1530	26	18	similar	similar	ADJ
dpc-1530	26	19	findings	finding	NOUN
dpc-1530	26	20	.	.	PUNCT
dpc-1530	27	1	these	these	PRON
dpc-1530	27	2	are	be	AUX
dpc-1530	27	3	both	both	PRON
dpc-1530	27	4	rare	rare	ADJ
dpc-1530	27	5	diseases	disease	NOUN
dpc-1530	27	6	that	that	PRON
dpc-1530	27	7	can	can	AUX
dpc-1530	27	8	manifest	manifest	VERB
dpc-1530	27	9	with	with	ADP
dpc-1530	27	10	urticarial	urticarial	ADJ
dpc-1530	27	11	rash	rash	NOUN
dpc-1530	27	12	,	,	PUNCT
dpc-1530	27	13	fever	fever	NOUN
dpc-1530	27	14	,	,	PUNCT
dpc-1530	27	15	and	and	CCONJ
dpc-1530	27	16	arthralgia	arthralgia	NOUN
dpc-1530	27	17	,	,	PUNCT
dpc-1530	27	18	mainly	mainly	ADV
dpc-1530	27	19	differing	differ	VERB
dpc-1530	27	20	by	by	ADP
dpc-1530	27	21	their	their	PRON
dpc-1530	27	22	etiopathology	etiopathology	NOUN
dpc-1530	27	23	and	and	CCONJ
dpc-1530	27	24	laboratory	laboratory	NOUN
dpc-1530	27	25	findings	finding	NOUN
dpc-1530	27	26	[	[	X
dpc-1530	27	27	1,2	1,2	NUM
dpc-1530	27	28	]	]	PUNCT
dpc-1530	27	29	.	.	PUNCT
dpc-1530	28	1	sslr	sslr	PROPN
dpc-1530	28	2	pathogenesis	pathogenesis	NOUN
dpc-1530	28	3	remains	remain	VERB
dpc-1530	28	4	unclear	unclear	ADJ
dpc-1530	28	5	but	but	CCONJ
dpc-1530	28	6	is	be	AUX
dpc-1530	28	7	probably	probably	ADV
dpc-1530	28	8	related	relate	VERB
dpc-1530	28	9	to	to	ADP
dpc-1530	28	10	an	an	DET
dpc-1530	28	11	inflammatory	inflammatory	ADJ
dpc-1530	28	12	response	response	NOUN
dpc-1530	28	13	to	to	ADP
dpc-1530	28	14	drug	drug	NOUN
dpc-1530	28	15	metabolites	metabolite	NOUN
dpc-1530	28	16	,	,	PUNCT
dpc-1530	28	17	more	more	ADV
dpc-1530	28	18	commonly	commonly	ADV
dpc-1530	28	19	,	,	PUNCT
dpc-1530	28	20	following	follow	VERB
dpc-1530	28	21	beta	beta	NOUN
dpc-1530	28	22	-	-	PUNCT
dpc-1530	28	23	lactams	lactam	NOUN
dpc-1530	28	24	use	use	NOUN
dpc-1530	28	25	.	.	PUNCT
dpc-1530	29	1	it	it	PRON
dpc-1530	29	2	is	be	AUX
dpc-1530	29	3	not	not	PART
dpc-1530	29	4	mediated	mediate	VERB
dpc-1530	29	5	by	by	ADP
dpc-1530	29	6	immunocomplexes	immunocomplexe	NOUN
dpc-1530	29	7	and	and	CCONJ
dpc-1530	29	8	does	do	AUX
dpc-1530	29	9	not	not	PART
dpc-1530	29	10	manifest	manifest	VERB
dpc-1530	29	11	hypocomplementemia	hypocomplementemia	NOUN
dpc-1530	30	1	[	[	X
dpc-1530	30	2	1,2	1,2	NUM
dpc-1530	30	3	]	]	PUNCT
dpc-1530	30	4	.	.	PUNCT
dpc-1530	31	1	case	case	NOUN
dpc-1530	31	2	report	report	VERB
dpc-1530	31	3	an	an	DET
dpc-1530	31	4	18	18	NUM
dpc-1530	31	5	-	-	PUNCT
dpc-1530	31	6	month	month	NOUN
dpc-1530	31	7	-	-	PUNCT
dpc-1530	31	8	old	old	ADJ
dpc-1530	31	9	girl	girl	NOUN
dpc-1530	31	10	,	,	PUNCT
dpc-1530	31	11	presented	present	VERB
dpc-1530	31	12	with	with	ADP
dpc-1530	31	13	spread	spread	ADJ
dpc-1530	31	14	,	,	PUNCT
dpc-1530	31	15	non	non	ADJ
dpc-1530	31	16	-	-	ADJ
dpc-1530	31	17	pruritic	pruritic	ADJ
dpc-1530	31	18	,	,	PUNCT
dpc-1530	31	19	erythematous	erythematous	ADJ
dpc-1530	31	20	-	-	PUNCT
dpc-1530	31	21	edematous	edematous	ADJ
dpc-1530	31	22	plaques	plaque	NOUN
dpc-1530	31	23	(	(	PUNCT
dpc-1530	31	24	some	some	DET
dpc-1530	31	25	violaceous	violaceous	NOUN
dpc-1530	31	26	)	)	PUNCT
dpc-1530	31	27	characterized	characterize	VERB
dpc-1530	31	28	by	by	ADP
dpc-1530	31	29	irregular	irregular	ADJ
dpc-1530	31	30	borders	border	NOUN
dpc-1530	31	31	(	(	PUNCT
dpc-1530	31	32	figure	figure	NOUN
dpc-1530	31	33	1a	1a	NOUN
dpc-1530	31	34	)	)	PUNCT
dpc-1530	31	35	.	.	PUNCT
dpc-1530	32	1	2	2	NUM
dpc-1530	32	2	days	day	NOUN
dpc-1530	32	3	after	after	ADV
dpc-1530	32	4	,	,	PUNCT
dpc-1530	32	5	a	a	DET
dpc-1530	32	6	violaceous	violaceous	ADJ
dpc-1530	32	7	inner	inner	ADJ
dpc-1530	32	8	halo	halo	NOUN
dpc-1530	32	9	appeared	appear	VERB
dpc-1530	32	10	on	on	ADP
dpc-1530	32	11	the	the	DET
dpc-1530	32	12	plaques	plaque	NOUN
dpc-1530	32	13	and	and	CCONJ
dpc-1530	32	14	the	the	DET
dpc-1530	32	15	patient	patient	NOUN
dpc-1530	32	16	developed	develop	VERB
dpc-1530	32	17	systemic	systemic	ADJ
dpc-1530	32	18	symptoms	symptom	NOUN
dpc-1530	32	19	,	,	PUNCT
dpc-1530	32	20	including	include	VERB
dpc-1530	32	21	joint	joint	ADJ
dpc-1530	32	22	edema	edema	NOUN
dpc-1530	32	23	,	,	PUNCT
dpc-1530	32	24	arthralgia	arthralgia	NOUN
dpc-1530	32	25	,	,	PUNCT
dpc-1530	32	26	limited	limited	ADJ
dpc-1530	32	27	mobility	mobility	NOUN
dpc-1530	32	28	,	,	PUNCT
dpc-1530	32	29	irritability	irritability	NOUN
dpc-1530	32	30	,	,	PUNCT
dpc-1530	32	31	hyporexia	hyporexia	NOUN
dpc-1530	32	32	,	,	PUNCT
dpc-1530	32	33	and	and	CCONJ
dpc-1530	32	34	fever	fever	NOUN
dpc-1530	32	35	(	(	PUNCT
dpc-1530	32	36	figure	figure	NOUN
dpc-1530	32	37	1b	1b	NUM
dpc-1530	32	38	and	and	CCONJ
dpc-1530	32	39	2	2	NUM
dpc-1530	32	40	)	)	PUNCT
dpc-1530	32	41	.	.	PUNCT
dpc-1530	33	1	the	the	DET
dpc-1530	33	2	patient	patient	NOUN
dpc-1530	33	3	had	have	AUX
dpc-1530	33	4	previously	previously	ADV
dpc-1530	33	5	received	receive	VERB
dpc-1530	33	6	oral	oral	ADJ
dpc-1530	33	7	amoxicillin	amoxicillin	NOUN
dpc-1530	33	8	/	/	SYM
dpc-1530	33	9	clavulanate	clavulanate	NOUN
dpc-1530	33	10	and	and	CCONJ
dpc-1530	33	11	dipyrone	dipyrone	NOUN
dpc-1530	33	12	treatment	treatment	NOUN
dpc-1530	33	13	5	5	NUM
dpc-1530	33	14	days	day	NOUN
dpc-1530	33	15	before	before	SCONJ
dpc-1530	33	16	the	the	DET
dpc-1530	33	17	skin	skin	NOUN
dpc-1530	33	18	lesions	lesion	NOUN
dpc-1530	33	19	appeared	appear	VERB
dpc-1530	33	20	,	,	PUNCT
dpc-1530	33	21	due	due	ADP
dpc-1530	33	22	to	to	ADP
dpc-1530	33	23	cough	cough	NOUN
dpc-1530	33	24	and	and	CCONJ
dpc-1530	33	25	fever	fever	NOUN
dpc-1530	33	26	.	.	PUNCT
dpc-1530	34	1	oral	oral	ADJ
dpc-1530	34	2	prednisone	prednisone	PROPN
dpc-1530	34	3	0,5mg	0,5mg	PROPN
dpc-1530	34	4	/	/	SYM
dpc-1530	34	5	kg	kg	NOUN
dpc-1530	34	6	and	and	CCONJ
dpc-1530	34	7	hydroxyzine	hydroxyzine	PROPN
dpc-1530	34	8	did	do	AUX
dpc-1530	34	9	not	not	PART
dpc-1530	34	10	help	help	VERB
dpc-1530	34	11	fade	fade	VERB
dpc-1530	34	12	the	the	DET
dpc-1530	34	13	lesions	lesion	NOUN
dpc-1530	34	14	and	and	CCONJ
dpc-1530	34	15	following	follow	VERB
dpc-1530	34	16	further	further	ADJ
dpc-1530	34	17	clinical	clinical	ADJ
dpc-1530	34	18	deterioration	deterioration	NOUN
dpc-1530	34	19	the	the	DET
dpc-1530	34	20	situation	situation	NOUN
dpc-1530	34	21	worsened	worsen	VERB
dpc-1530	34	22	until	until	SCONJ
dpc-1530	34	23	she	she	PRON
dpc-1530	34	24	was	be	AUX
dpc-1530	34	25	admitted	admit	VERB
dpc-1530	34	26	at	at	ADP
dpc-1530	34	27	the	the	DET
dpc-1530	34	28	intensive	intensive	ADJ
dpc-1530	34	29	care	care	NOUN
dpc-1530	34	30	unit	unit	NOUN
dpc-1530	34	31	(	(	PUNCT
dpc-1530	34	32	icu	icu	PROPN
dpc-1530	34	33	)	)	PUNCT
dpc-1530	34	34	.	.	PUNCT
dpc-1530	35	1	2	2	NUM
dpc-1530	35	2	letter	letter	NOUN
dpc-1530	35	3	|	|	ADV
dpc-1530	35	4	dermatol	dermatol	ADJ
dpc-1530	35	5	pract	pract	NOUN
dpc-1530	35	6	concept	concept	NOUN
dpc-1530	35	7	.	.	PUNCT
dpc-1530	36	1	2021	2021	NUM
dpc-1530	36	2	;	;	PUNCT
dpc-1530	37	1	11(3	11(3	NUM
dpc-1530	37	2	):	):	PUNCT
dpc-1530	37	3	e2021029	e2021029	NOUN
dpc-1530	37	4	figure	figure	NOUN
dpc-1530	37	5	1	1	NUM
dpc-1530	37	6	.	.	PUNCT
dpc-1530	38	1	(	(	PUNCT
dpc-1530	38	2	a)diffuse	a)diffuse	NOUN
dpc-1530	38	3	erythematous	erythematous	ADJ
dpc-1530	38	4	and	and	CCONJ
dpc-1530	38	5	violaceous	violaceous	ADJ
dpc-1530	38	6	,	,	PUNCT
dpc-1530	38	7	edematous	edematous	ADJ
dpc-1530	38	8	plaques	plaque	NOUN
dpc-1530	38	9	on	on	ADP
dpc-1530	38	10	trunk	trunk	NOUN
dpc-1530	38	11	,	,	PUNCT
dpc-1530	38	12	axillary	axillary	ADJ
dpc-1530	38	13	region	region	NOUN
dpc-1530	38	14	,	,	PUNCT
dpc-1530	38	15	and	and	CCONJ
dpc-1530	38	16	face	face	NOUN
dpc-1530	38	17	.	.	PUNCT
dpc-1530	39	1	(	(	PUNCT
dpc-1530	39	2	b	b	X
dpc-1530	39	3	)	)	PUNCT
dpc-1530	39	4	after	after	ADP
dpc-1530	39	5	2	2	NUM
dpc-1530	39	6	days	day	NOUN
dpc-1530	39	7	,	,	PUNCT
dpc-1530	39	8	appearance	appearance	NOUN
dpc-1530	39	9	internal	internal	ADJ
dpc-1530	39	10	violaceous	violaceous	PROPN
dpc-1530	39	11	halo	halo	PROPN
dpc-1530	39	12	.	.	PUNCT
dpc-1530	40	1	figure	figure	NOUN
dpc-1530	40	2	2	2	NUM
dpc-1530	40	3	.	.	PUNCT
dpc-1530	41	1	diffuse	diffuse	VERB
dpc-1530	41	2	arcuate	arcuate	ADJ
dpc-1530	41	3	and	and	CCONJ
dpc-1530	41	4	annular	annular	ADJ
dpc-1530	41	5	pink	pink	ADJ
dpc-1530	41	6	edematous	edematous	ADJ
dpc-1530	41	7	plaques	plaque	NOUN
dpc-1530	41	8	with	with	ADP
dpc-1530	41	9	central	central	ADJ
dpc-1530	41	10	purple	purple	ADJ
dpc-1530	41	11	annular	annular	ADJ
dpc-1530	41	12	patches	patch	NOUN
dpc-1530	41	13	surrounding	surround	VERB
dpc-1530	41	14	a	a	DET
dpc-1530	41	15	yellowish	yellowish	ADJ
dpc-1530	41	16	center	center	NOUN
dpc-1530	41	17	.	.	PUNCT
dpc-1530	42	1	on	on	ADP
dpc-1530	42	2	the	the	DET
dpc-1530	42	3	first	first	ADJ
dpc-1530	42	4	day	day	NOUN
dpc-1530	42	5	of	of	ADP
dpc-1530	42	6	hospitalization	hospitalization	NOUN
dpc-1530	42	7	leukocytosis	leukocytosis	NOUN
dpc-1530	42	8	was	be	AUX
dpc-1530	42	9	at	at	ADP
dpc-1530	42	10	24.730	24.730	NUM
dpc-1530	42	11	/	/	SYM
dpc-1530	42	12	mm³	mm³	PROPN
dpc-1530	42	13	,	,	PUNCT
dpc-1530	42	14	after	after	ADP
dpc-1530	42	15	2	2	NUM
dpc-1530	42	16	days	day	NOUN
dpc-1530	42	17	it	it	PRON
dpc-1530	42	18	raised	raise	VERB
dpc-1530	42	19	to	to	ADP
dpc-1530	42	20	31.800	31.800	NUM
dpc-1530	42	21	/	/	SYM
dpc-1530	42	22	mm³	mm³	PROPN
dpc-1530	42	23	;	;	PUNCT
dpc-1530	42	24	c	c	NOUN
dpc-1530	42	25	reactive	reactive	ADJ
dpc-1530	42	26	protein	protein	NOUN
dpc-1530	42	27	analysis	analysis	NOUN
dpc-1530	42	28	increased	increase	VERB
dpc-1530	42	29	from	from	ADP
dpc-1530	42	30	29,9mg	29,9mg	PROPN
dpc-1530	42	31	/	/	SYM
dpc-1530	42	32	dl	dl	PROPN
dpc-1530	42	33	on	on	ADP
dpc-1530	42	34	the	the	DET
dpc-1530	42	35	first	first	ADJ
dpc-1530	42	36	day	day	NOUN
dpc-1530	42	37	,	,	PUNCT
dpc-1530	42	38	to	to	ADP
dpc-1530	42	39	90,2	90,2	VERB
dpc-1530	42	40	mg	mg	PROPN
dpc-1530	42	41	/	/	SYM
dpc-1530	42	42	dl	dl	PROPN
dpc-1530	42	43	.	.	PROPN
dpc-1530	42	44	liver	liver	NOUN
dpc-1530	42	45	enzymes	enzyme	NOUN
dpc-1530	42	46	and	and	CCONJ
dpc-1530	42	47	renal	renal	ADJ
dpc-1530	42	48	function	function	NOUN
dpc-1530	42	49	were	be	AUX
dpc-1530	42	50	normal	normal	ADJ
dpc-1530	42	51	.	.	PUNCT
dpc-1530	43	1	transthoracic	transthoracic	PROPN
dpc-1530	43	2	echocardiogram	echocardiogram	NOUN
dpc-1530	43	3	did	do	AUX
dpc-1530	43	4	not	not	PART
dpc-1530	43	5	demonstrate	demonstrate	VERB
dpc-1530	43	6	any	any	DET
dpc-1530	43	7	abnormality	abnormality	NOUN
dpc-1530	43	8	.	.	PUNCT
dpc-1530	44	1	a	a	DET
dpc-1530	44	2	skin	skin	NOUN
dpc-1530	44	3	biopsy	biopsy	NOUN
dpc-1530	44	4	was	be	AUX
dpc-1530	44	5	performed	perform	VERB
dpc-1530	44	6	,	,	PUNCT
dpc-1530	44	7	and	and	CCONJ
dpc-1530	44	8	the	the	DET
dpc-1530	44	9	histopathology	histopathology	NOUN
dpc-1530	44	10	showed	show	VERB
dpc-1530	44	11	normal	normal	ADJ
dpc-1530	44	12	epidermis	epidermis	NOUN
dpc-1530	44	13	,	,	PUNCT
dpc-1530	44	14	perivascular	perivascular	ADJ
dpc-1530	44	15	,	,	PUNCT
dpc-1530	44	16	periadnexal	periadnexal	NOUN
dpc-1530	44	17	,	,	PUNCT
dpc-1530	44	18	and	and	CCONJ
dpc-1530	44	19	interstitial	interstitial	ADJ
dpc-1530	44	20	inflammatory	inflammatory	ADJ
dpc-1530	44	21	infiltrate	infiltrate	NOUN
dpc-1530	44	22	,	,	PUNCT
dpc-1530	44	23	consisting	consist	VERB
dpc-1530	44	24	of	of	ADP
dpc-1530	44	25	lymphocytes	lymphocyte	NOUN
dpc-1530	44	26	,	,	PUNCT
dpc-1530	44	27	neutrophils	neutrophil	NOUN
dpc-1530	44	28	and	and	CCONJ
dpc-1530	44	29	numerous	numerous	ADJ
dpc-1530	44	30	eosinophils	eosinophil	NOUN
dpc-1530	44	31	,	,	PUNCT
dpc-1530	44	32	in	in	ADP
dpc-1530	44	33	addition	addition	NOUN
dpc-1530	44	34	to	to	ADP
dpc-1530	44	35	edema	edema	VERB
dpc-1530	44	36	,	,	PUNCT
dpc-1530	44	37	without	without	ADP
dpc-1530	44	38	vasculitis	vasculitis	PROPN
dpc-1530	44	39	(	(	PUNCT
dpc-1530	44	40	figure	figure	NOUN
dpc-1530	44	41	3	3	NUM
dpc-1530	44	42	)	)	PUNCT
dpc-1530	44	43	.	.	PUNCT
dpc-1530	45	1	antibiotic	antibiotic	ADJ
dpc-1530	45	2	treatment	treatment	NOUN
dpc-1530	45	3	was	be	AUX
dpc-1530	45	4	suspended	suspend	VERB
dpc-1530	45	5	,	,	PUNCT
dpc-1530	45	6	antipyretic	antipyretic	ADJ
dpc-1530	45	7	and	and	CCONJ
dpc-1530	45	8	oral	oral	ADJ
dpc-1530	45	9	corticosteroids	corticosteroid	NOUN
dpc-1530	45	10	(	(	PUNCT
dpc-1530	45	11	0,5	0,5	NUM
dpc-1530	45	12	mg	mg	PROPN
dpc-1530	45	13	/	/	SYM
dpc-1530	45	14	kg	kg	PROPN
dpc-1530	45	15	/	/	SYM
dpc-1530	45	16	day	day	NOUN
dpc-1530	45	17	)	)	PUNCT
dpc-1530	45	18	were	be	AUX
dpc-1530	45	19	maintained	maintain	VERB
dpc-1530	45	20	,	,	PUNCT
dpc-1530	45	21	in	in	ADP
dpc-1530	45	22	addition	addition	NOUN
dpc-1530	45	23	to	to	ADP
dpc-1530	45	24	venous	venous	ADJ
dpc-1530	45	25	hydration	hydration	NOUN
dpc-1530	45	26	.	.	PUNCT
dpc-1530	46	1	after	after	ADP
dpc-1530	46	2	3	3	NUM
dpc-1530	46	3	days	day	NOUN
dpc-1530	46	4	of	of	ADP
dpc-1530	46	5	hospitalization	hospitalization	NOUN
dpc-1530	46	6	,	,	PUNCT
dpc-1530	46	7	she	she	PRON
dpc-1530	46	8	was	be	AUX
dpc-1530	46	9	discharged	discharge	VERB
dpc-1530	46	10	with	with	ADP
dpc-1530	46	11	significant	significant	ADJ
dpc-1530	46	12	improvement	improvement	NOUN
dpc-1530	46	13	.	.	PUNCT
dpc-1530	47	1	conclusions	conclusion	NOUN
dpc-1530	47	2	diagnosis	diagnosis	NOUN
dpc-1530	47	3	of	of	ADP
dpc-1530	47	4	sslr	sslr	NOUN
dpc-1530	47	5	is	be	AUX
dpc-1530	47	6	clinical	clinical	ADJ
dpc-1530	47	7	and	and	CCONJ
dpc-1530	47	8	can	can	AUX
dpc-1530	47	9	be	be	AUX
dpc-1530	47	10	made	make	VERB
dpc-1530	47	11	when	when	SCONJ
dpc-1530	47	12	annular	annular	ADJ
dpc-1530	47	13	,	,	PUNCT
dpc-1530	47	14	erythematous	erythematous	ADJ
dpc-1530	47	15	edematous	edematous	ADJ
dpc-1530	47	16	plaques	plaque	NOUN
dpc-1530	47	17	,	,	PUNCT
dpc-1530	47	18	similar	similar	ADJ
dpc-1530	47	19	to	to	ADP
dpc-1530	47	20	an	an	DET
dpc-1530	47	21	urticarial	urticarial	ADJ
dpc-1530	47	22	reaction	reaction	NOUN
dpc-1530	47	23	,	,	PUNCT
dpc-1530	47	24	usually	usually	ADV
dpc-1530	47	25	turning	turn	VERB
dpc-1530	47	26	violet	violet	NOUN
dpc-1530	47	27	,	,	PUNCT
dpc-1530	47	28	giving	give	VERB
dpc-1530	47	29	the	the	DET
dpc-1530	47	30	lesion	lesion	NOUN
dpc-1530	47	31	an	an	DET
dpc-1530	47	32	ecchymotic	ecchymotic	ADJ
dpc-1530	47	33	aspect	aspect	NOUN
dpc-1530	47	34	,	,	PUNCT
dpc-1530	47	35	appear	appear	VERB
dpc-1530	47	36	combined	combine	VERB
dpc-1530	47	37	with	with	ADP
dpc-1530	47	38	systemic	systemic	ADJ
dpc-1530	47	39	symptoms	symptom	NOUN
dpc-1530	47	40	,	,	PUNCT
dpc-1530	47	41	such	such	ADJ
dpc-1530	47	42	as	as	ADP
dpc-1530	47	43	arthralgia	arthralgia	NOUN
dpc-1530	47	44	/	/	SYM
dpc-1530	47	45	arthritis	arthritis	NOUN
dpc-1530	47	46	,	,	PUNCT
dpc-1530	47	47	lymphadenopathy	lymphadenopathy	ADJ
dpc-1530	47	48	,	,	PUNCT
dpc-1530	47	49	malaise	malaise	NOUN
dpc-1530	47	50	,	,	PUNCT
dpc-1530	47	51	and	and	CCONJ
dpc-1530	47	52	fever	fever	NOUN
dpc-1530	47	53	,	,	PUNCT
dpc-1530	47	54	following	follow	VERB
dpc-1530	47	55	8	8	NUM
dpc-1530	47	56	to	to	PART
dpc-1530	47	57	14	14	NUM
dpc-1530	47	58	days	day	NOUN
dpc-1530	47	59	of	of	ADP
dpc-1530	47	60	drug	drug	NOUN
dpc-1530	47	61	exposure	exposure	NOUN
dpc-1530	47	62	.	.	PUNCT
dpc-1530	48	1	sslr	sslr	PROPN
dpc-1530	48	2	diagnosis	diagnosis	NOUN
dpc-1530	48	3	,	,	PUNCT
dpc-1530	48	4	needs	need	VERB
dpc-1530	48	5	however	however	ADV
dpc-1530	48	6	to	to	PART
dpc-1530	48	7	be	be	AUX
dpc-1530	48	8	distinguished	distinguish	VERB
dpc-1530	48	9	from	from	ADP
dpc-1530	48	10	other	other	ADJ
dpc-1530	48	11	,	,	PUNCT
dpc-1530	48	12	potentially	potentially	ADV
dpc-1530	48	13	more	more	ADV
dpc-1530	48	14	serious	serious	ADJ
dpc-1530	48	15	conditions	condition	NOUN
dpc-1530	48	16	such	such	ADJ
dpc-1530	48	17	as	as	ADP
dpc-1530	48	18	lyme	lyme	NOUN
dpc-1530	48	19	disease	disease	NOUN
dpc-1530	48	20	,	,	PUNCT
dpc-1530	48	21	endocarditis	endocarditis	NOUN
dpc-1530	48	22	,	,	PUNCT
dpc-1530	48	23	erythema	erythema	ADV
dpc-1530	48	24	figure	figure	VERB
dpc-1530	48	25	3	3	NUM
dpc-1530	48	26	.	.	PUNCT
dpc-1530	49	1	(	(	PUNCT
dpc-1530	49	2	h&e	h&e	PROPN
dpc-1530	49	3	,	,	PUNCT
dpc-1530	49	4	x100	x100	PROPN
dpc-1530	49	5	)	)	PUNCT
dpc-1530	49	6	(	(	PUNCT
dpc-1530	49	7	magnification	magnification	NOUN
dpc-1530	49	8	x400	x400	PROPN
dpc-1530	49	9	)	)	PUNCT
dpc-1530	49	10	normal	normal	ADJ
dpc-1530	49	11	epidermis	epidermis	NOUN
dpc-1530	49	12	,	,	PUNCT
dpc-1530	49	13	and	and	CCONJ
dpc-1530	49	14	perivascular	perivascular	ADJ
dpc-1530	49	15	,	,	PUNCT
dpc-1530	49	16	periadnexal	periadnexal	NOUN
dpc-1530	49	17	and	and	CCONJ
dpc-1530	49	18	interstitial	interstitial	ADJ
dpc-1530	49	19	cell	cell	NOUN
dpc-1530	49	20	infiltrate	infiltrate	VERB
dpc-1530	49	21	inflammatory	inflammatory	ADJ
dpc-1530	49	22	infiltrate	infiltrate	NOUN
dpc-1530	49	23	,	,	PUNCT
dpc-1530	49	24	consisting	consist	VERB
dpc-1530	49	25	of	of	ADP
dpc-1530	49	26	lymphocytes	lymphocyte	NOUN
dpc-1530	49	27	,	,	PUNCT
dpc-1530	49	28	neutrophils	neutrophil	NOUN
dpc-1530	49	29	and	and	CCONJ
dpc-1530	49	30	eosinophils	eosinophil	VERB
dpc-1530	49	31	,	,	PUNCT
dpc-1530	49	32	in	in	ADP
dpc-1530	49	33	addition	addition	NOUN
dpc-1530	49	34	to	to	ADP
dpc-1530	49	35	edema	edema	VERB
dpc-1530	49	36	without	without	ADP
dpc-1530	49	37	vasculitis	vasculitis	PROPN
dpc-1530	49	38	.	.	PUNCT
dpc-1530	50	1	letter	letter	NOUN
dpc-1530	51	1	|	|	ADV
dpc-1530	51	2	dermatol	dermatol	ADJ
dpc-1530	51	3	pract	pract	NOUN
dpc-1530	51	4	concept	concept	NOUN
dpc-1530	51	5	.	.	PUNCT
dpc-1530	52	1	2021	2021	NUM
dpc-1530	52	2	;	;	PUNCT
dpc-1530	53	1	11(3	11(3	NUM
dpc-1530	53	2	):	):	PUNCT
dpc-1530	53	3	e2021029	e2021029	PROPN
dpc-1530	53	4	3	3	NUM
dpc-1530	53	5	multiforme	multiforme	NOUN
dpc-1530	53	6	,	,	PUNCT
dpc-1530	53	7	kawasaki	kawasaki	PROPN
dpc-1530	53	8	’s	’s	PART
dpc-1530	53	9	disease	disease	NOUN
dpc-1530	53	10	,	,	PUNCT
dpc-1530	53	11	and	and	CCONJ
dpc-1530	53	12	in	in	ADP
dpc-1530	53	13	some	some	DET
dpc-1530	53	14	rare	rare	ADJ
dpc-1530	53	15	situations	situation	NOUN
dpc-1530	53	16	to	to	ADP
dpc-1530	53	17	neoplastic	neoplastic	ADJ
dpc-1530	53	18	diseases	disease	NOUN
dpc-1530	53	19	.	.	PUNCT
dpc-1530	54	1	in	in	ADP
dpc-1530	54	2	this	this	DET
dpc-1530	54	3	case	case	NOUN
dpc-1530	54	4	,	,	PUNCT
dpc-1530	54	5	one	one	NUM
dpc-1530	54	6	of	of	ADP
dpc-1530	54	7	the	the	DET
dpc-1530	54	8	first	first	ADJ
dpc-1530	54	9	hypotheses	hypothesis	NOUN
dpc-1530	54	10	considered	consider	VERB
dpc-1530	54	11	before	before	ADP
dpc-1530	54	12	the	the	DET
dpc-1530	54	13	dermatology	dermatology	NOUN
dpc-1530	54	14	evaluation	evaluation	NOUN
dpc-1530	54	15	,	,	PUNCT
dpc-1530	54	16	was	be	AUX
dpc-1530	54	17	meningococcemia	meningococcemia	NOUN
dpc-1530	54	18	,	,	PUNCT
dpc-1530	54	19	and	and	CCONJ
dpc-1530	54	20	the	the	DET
dpc-1530	54	21	patient	patient	NOUN
dpc-1530	54	22	almost	almost	ADV
dpc-1530	54	23	underwent	undergo	VERB
dpc-1530	54	24	a	a	DET
dpc-1530	54	25	lumbar	lumbar	NOUN
dpc-1530	54	26	puncture	puncture	NOUN
dpc-1530	54	27	.	.	PUNCT
dpc-1530	55	1	the	the	DET
dpc-1530	55	2	treatment	treatment	NOUN
dpc-1530	55	3	involves	involve	VERB
dpc-1530	55	4	the	the	DET
dpc-1530	55	5	discontinuation	discontinuation	NOUN
dpc-1530	55	6	of	of	ADP
dpc-1530	55	7	the	the	DET
dpc-1530	55	8	culprit	culprit	NOUN
dpc-1530	55	9	drug	drug	NOUN
dpc-1530	55	10	and	and	CCONJ
dpc-1530	55	11	,	,	PUNCT
dpc-1530	55	12	if	if	SCONJ
dpc-1530	55	13	necessary	necessary	ADJ
dpc-1530	55	14	,	,	PUNCT
dpc-1530	55	15	the	the	DET
dpc-1530	55	16	use	use	NOUN
dpc-1530	55	17	of	of	ADP
dpc-1530	55	18	corticosteroids	corticosteroid	NOUN
dpc-1530	55	19	,	,	PUNCT
dpc-1530	55	20	anti	anti	ADJ
dpc-1530	55	21	-	-	ADJ
dpc-1530	55	22	inflammatory	inflammatory	ADJ
dpc-1530	55	23	,	,	PUNCT
dpc-1530	55	24	antihistamines	antihistamine	NOUN
dpc-1530	55	25	,	,	PUNCT
dpc-1530	55	26	or	or	CCONJ
dpc-1530	55	27	sometimes	sometimes	ADV
dpc-1530	55	28	,	,	PUNCT
dpc-1530	55	29	intravenous	intravenous	ADJ
dpc-1530	55	30	gamma	gamma	NOUN
dpc-1530	55	31	globulin	globulin	PROPN
dpc-1530	55	32	administration	administration	NOUN
dpc-1530	56	1	[	[	X
dpc-1530	56	2	1,2	1,2	NUM
dpc-1530	56	3	]	]	PUNCT
dpc-1530	56	4	.	.	PUNCT
dpc-1530	57	1	early	early	ADJ
dpc-1530	57	2	recognition	recognition	NOUN
dpc-1530	57	3	of	of	ADP
dpc-1530	57	4	this	this	DET
dpc-1530	57	5	condition	condition	NOUN
dpc-1530	57	6	leads	lead	VERB
dpc-1530	57	7	to	to	ADP
dpc-1530	57	8	less	less	ADJ
dpc-1530	57	9	family	family	NOUN
dpc-1530	57	10	anxiety	anxiety	NOUN
dpc-1530	57	11	and	and	CCONJ
dpc-1530	57	12	a	a	DET
dpc-1530	57	13	non	non	ADJ
dpc-1530	57	14	-	-	ADJ
dpc-1530	57	15	iatrogenic	iatrogenic	ADJ
dpc-1530	57	16	management	management	NOUN
dpc-1530	57	17	,	,	PUNCT
dpc-1530	57	18	avoiding	avoid	VERB
dpc-1530	57	19	unnecessary	unnecessary	ADJ
dpc-1530	57	20	and	and	CCONJ
dpc-1530	57	21	potentially	potentially	ADV
dpc-1530	57	22	harmful	harmful	ADJ
dpc-1530	57	23	prescriptions	prescription	NOUN
dpc-1530	57	24	[	[	X
dpc-1530	57	25	1,2	1,2	NUM
dpc-1530	57	26	]	]	PUNCT
dpc-1530	57	27	.	.	PUNCT
dpc-1530	58	1	references	reference	NOUN
dpc-1530	58	2	1	1	NUM
dpc-1530	58	3	.	.	PUNCT
dpc-1530	58	4	barreira	barreira	PROPN
dpc-1530	58	5	p	p	PROPN
dpc-1530	58	6	,	,	PUNCT
dpc-1530	58	7	gomes	gomes	PROPN
dpc-1530	58	8	e.	e.	PROPN
dpc-1530	58	9	serum	serum	PROPN
dpc-1530	58	10	sickness	sickness	PROPN
dpc-1530	58	11	-like	-like	PROPN
dpc-1530	58	12	reaction	reaction	NOUN
dpc-1530	58	13	associated	associate	VERB
dpc-1530	58	14	with	with	ADP
dpc-1530	58	15	drugs	drug	NOUN
dpc-1530	58	16	intake	intake	NOUN
dpc-1530	58	17	in	in	ADP
dpc-1530	58	18	pediatric	pediatric	ADJ
dpc-1530	58	19	age	age	NOUN
dpc-1530	58	20	.	.	PUNCT
dpc-1530	59	1	rev	rev	VERB
dpc-1530	59	2	port	port	NOUN
dpc-1530	59	3	imunoalergologia	imunoalergologia	NOUN
dpc-1530	59	4	.	.	PUNCT
dpc-1530	60	1	2013;21(4):267–74	2013;21(4):267–74	NUM
dpc-1530	60	2	.	.	NOUN
dpc-1530	61	1	2	2	X
dpc-1530	61	2	.	.	PUNCT
dpc-1530	62	1	yorulmaz	yorulmaz	NOUN
dpc-1530	62	2	a	a	PRON
dpc-1530	62	3	,	,	PUNCT
dpc-1530	62	4	akın	akın	PROPN
dpc-1530	62	5	f	f	NOUN
dpc-1530	62	6	,	,	PUNCT
dpc-1530	62	7	sert	sert	NOUN
dpc-1530	62	8	a	a	PRON
dpc-1530	62	9	,	,	PUNCT
dpc-1530	62	10	ağır	ağır	PROPN
dpc-1530	62	11	ma	ma	PROPN
dpc-1530	62	12	,	,	PUNCT
dpc-1530	62	13	yılmaz	yılmaz	PROPN
dpc-1530	62	14	r	r	PROPN
dpc-1530	62	15	,	,	PUNCT
dpc-1530	62	16	arslan	arslan	PROPN
dpc-1530	62	17	ş	ş	PROPN
dpc-1530	62	18	.	.	PUNCT
dpc-1530	63	1	demographic	demographic	ADJ
dpc-1530	63	2	and	and	CCONJ
dpc-1530	63	3	clinical	clinical	ADJ
dpc-1530	63	4	characteristics	characteristic	NOUN
dpc-1530	63	5	of	of	ADP
dpc-1530	63	6	patients	patient	NOUN
dpc-1530	63	7	with	with	ADP
dpc-1530	63	8	serum	serum	NOUN
dpc-1530	63	9	sickness	sickness	NOUN
dpc-1530	63	10	-	-	PUNCT
dpc-1530	63	11	like	like	ADJ
dpc-1530	63	12	reaction	reaction	NOUN
dpc-1530	63	13	.	.	PUNCT
dpc-1530	64	1	clinical	clinical	ADJ
dpc-1530	64	2	rheumatology	rheumatology	NOUN
dpc-1530	64	3	.	.	PUNCT
dpc-1530	65	1	2018;37(5):1389	2018;37(5):1389	NUM
dpc-1530	65	2	–	–	PUNCT
dpc-1530	65	3	94	94	NUM
dpc-1530	65	4	.	.	PUNCT
dpc-1530	66	1	doi	doi	NOUN
dpc-1530	66	2	:	:	PUNCT
dpc-1530	66	3	10.1007	10.1007	NUM
dpc-1530	66	4	/	/	SYM
dpc-1530	66	5	s10067	s10067	NOUN
dpc-1530	66	6	-	-	PUNCT
dpc-1530	66	7	017	017	NUM
dpc-1530	66	8	-	-	PUNCT
dpc-1530	66	9	3777	3777	NUM
dpc-1530	66	10	-	-	PUNCT
dpc-1530	66	11	4	4	NUM
dpc-1530	66	12	.	.	PUNCT
dpc-1530	67	1	pmid	pmid	NOUN
dpc-1530	67	2	:	:	PUNCT
dpc-1530	67	3	28795234	28795234	NUM